Physician profile
Stephen Alan Shellhaas
NPI 1699883991
$204.21
in general payments reported to CMS, 2019-2025
9 companies · $14.81 in 2025
The $14.81 reported for 2025 was less than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $153 · 2023: $23.41 · 2024: $13.48 · 2025: $14.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $51.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $51.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $58.00 | 2021 | |
| Glaxosmithkline, LLC. | $38.22 | 2023-2025 | Bexsero, Pediarix, Rotarix |
| Amarin Pharma, INC. | $25.16 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.76 | 2021 | |
| Novo Nordisk INC | $13.92 | 2021 | |
| Sanofi Pasteur INC. | $13.48 | 2024 | |
| Alkermes, INC. | $13.45 | 2021 | |
| Daiichi Sankyo INC. | $13.32 | 2021 | |
| Abbvie INC. | $11.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Shellhaas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.